InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: Justfactsmam post# 33

Tuesday, 03/28/2017 7:37:03 AM

Tuesday, March 28, 2017 7:37:03 AM

Post# of 144
"Upgrade this AM by Chardan...Price Target: $65.00 (triple current SP). $65.00 based upon 3 different valuation methods with $65.00 being the "average"...meaning of course one or two were ABOVE $65.00."

Chardan notes: ... bullish on CRISPPR technology "vast potential" ...Editas has the greater upside potential vs other U.S. companies
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EDIT News